SPARC gets Orphan Drug Designation for Phenobarbital

05 Oct 2019 Evaluate

Sun Pharma Advanced Research Company (SPARC) has received Orphan Drug Designation from US Food and Drug Administration (USFDA) for Phenobarbital for the treatment of patients with neonatal seizures. The Orphan Drug Act provides economic incentives to encourage the development of drugs for diseases affecting fewer than 200,000 people in the United States.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

134.45 0.00 (0.00%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 650.90
Indegene 520.55
CMS Info Systems 339.50
Sagility 52.02
Smartworks Coworking 496.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×